How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

1,722 results for

Mycosis Fungoides

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

121. Risk Factors for Skin Infections in Mycosis Fungoides. (PubMed)

Risk Factors for Skin Infections in Mycosis Fungoides. Mycosis fungoides (MF) is the most frequent type of primary cutaneous natural killer and T-cell lymphoma. MF-required immunosuppressive therapies and MF-related immunosuppressive characteristics render patients with MF more prone to infections.To describe the clinical features of cutaneous infections observed in MF patients.A series of 56 MF patients were followed prospectively over 3 years and screened for cutaneous infections.Prospective

Full Text available with Trip Pro

2017 Dermatology

122. Unilesional plantar mycosis fungoides treated with topical photodynamic therapy - case report and review of the literature. (PubMed)

Unilesional plantar mycosis fungoides treated with topical photodynamic therapy - case report and review of the literature. Unilesional mycosis fungoides (UMF) and pagetoid reticulosis (PR) are variants of mycosis fungoides. Conventional therapy comprises surgical excision or radiotherapy, which may be associated with long-term side effects, especially when the lesion is located at a special site like the palms and soles. Therefore, alternative treatment options are needed to treat solitary

2017 Journal of the European Academy of Dermatology and Venereology

123. Recommendations for treatment in Folliculotropic Mycosis Fungoides: Report of the Dutch Cutaneous Lymphoma Group. (PubMed)

Recommendations for treatment in Folliculotropic Mycosis Fungoides: Report of the Dutch Cutaneous Lymphoma Group. Folliculotropic mycosis fungoides (FMF) is an aggressive variant of mycosis fungoides (MF) and generally less responsive to standard skin-directed therapies (SDTs). Recent studies distinguished indolent (early-stage FMF) and more aggressive (advanced-stage FMF) subgroups. The optimal treatment for both subgroups remains to be defined.To evaluate initial treatment results in patients

2017 British Journal of Dermatology

124. Case report: photo‐onycholysis after PUVA treatment for hypopigmented mycosis fungoides with response to topical steroid (PubMed)

Case report: photo‐onycholysis after PUVA treatment for hypopigmented mycosis fungoides with response to topical steroid Melanin in the nail bed in patients with skin type VI has been suggested to afford some protection against photo-onycholysis. We report a case of a 16-year-old male patient with skin type VI with onycholysis following PUVA treatment for hypopigmented mycosis fungoides. Symptoms resolved with the application of topical steroid.

Full Text available with Trip Pro

2017 Clinical Case Reports

125. Hypopigmented Mycosis Fungoides Treated with 308 nm Excimer Laser (PubMed)

Hypopigmented Mycosis Fungoides Treated with 308 nm Excimer Laser 29386841 2018 11 13 1013-9087 30 1 2018 Feb Annals of dermatology Ann Dermatol Hypopigmented Mycosis Fungoides Treated with 308 nm Excimer Laser. 93-95 10.5021/ad.2018.30.1.93 Yang Min-Young MY Department of Dermatology, Pusan National University School of Medicine, Busan, Korea. Jin Hyunju H Department of Dermatology, Pusan National University School of Medicine, Busan, Korea. You Hyang-Suk HS Department of Dermatology, Pusan

Full Text available with Trip Pro

2017 Annals of dermatology

126. Photodynamic Therapy in Treating Patients With Refractory Mycosis Fungoides

Photodynamic Therapy in Treating Patients With Refractory Mycosis Fungoides Photodynamic Therapy in Treating Patients With Refractory Mycosis Fungoides - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more (...) . Photodynamic Therapy in Treating Patients With Refractory Mycosis Fungoides The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03281811 Recruitment Status : Recruiting First Posted : September 13, 2017 Last Update Posted : November

2017 Clinical Trials

127. A Trial Assessing the Effect of Pembrolizumab Combined With Radiotherapy in Patients With Relapsed, Refractory, Specified Stages of Cutaneous T-cell Lymphoma (CTCL) Mycosis Fungoides (MF)/Sezary Syndrome (SS)

A Trial Assessing the Effect of Pembrolizumab Combined With Radiotherapy in Patients With Relapsed, Refractory, Specified Stages of Cutaneous T-cell Lymphoma (CTCL) Mycosis Fungoides (MF)/Sezary Syndrome (SS) A Trial Assessing the Effect of Pembrolizumab Combined With Radiotherapy in Patients With Relapsed, Refractory, Specified Stages of Cutaneous T-cell Lymphoma (CTCL) Mycosis Fungoides (MF)/Sezary Syndrome (SS) - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record (...) managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. A Trial Assessing the Effect of Pembrolizumab Combined With Radiotherapy in Patients With Relapsed, Refractory, Specified Stages of Cutaneous T-cell Lymphoma (CTCL) Mycosis Fungoides (MF)/Sezary Syndrome (SS) (PORT) The safety

2017 Clinical Trials

128. Syringotropic Mycosis Fungoides: A Rare Form of Cutaneous T-cell Lymphoma Enabling a Histopathologic “Sigh of Relief” (PubMed)

Syringotropic Mycosis Fungoides: A Rare Form of Cutaneous T-cell Lymphoma Enabling a Histopathologic “Sigh of Relief” Syringotropic mycosis fungoides (STMF) is a very rare variant of cutaneous T-cell lymphoma. It follows a much milder disease course than its clinically indistinguishable adnexal counterpart, folliculotropic mycosis fungoides (FMF). We report a case of a 36-year-old man who presented with erythematous, studded papules and plaques on the left upper extremity and right anterior (...) thigh diagnosed as mycosis fungoides (MF) Stage 1A on initial superficial shave biopsy. Lesions recurred after initial improvement with narrow-band ultraviolet light therapy demonstrating a concentration of abnormal lymphocytes around eccrine sweat glands on repeat biopsy consistent with STMF. Although the deeper, periadnexal infiltrate found in both STMF and FMF confers increased resistance to skin-directed therapies effective in classic MF, these entities diverge with respect to their clinical

Full Text available with Trip Pro

2017 The American Journal of dermatopathology

129. Frequency and Risk Factors for Secondary Malignancies in Patients with Mycosis Fungoides (PubMed)

Frequency and Risk Factors for Secondary Malignancies in Patients with Mycosis Fungoides 28832009 2018 10 05 2018 11 13 1308-5263 34 4 2017 12 01 Turkish journal of haematology : official journal of Turkish Society of Haematology Turk J Haematol Frequency and Risk Factors for Secondary Malignancies in Patients with Mycosis Fungoides. 378-379 10.4274/tjh.2017.0234 Cengiz Fatma Pelin FP Bezmialem Vakıf University Faculty of Medicine, Department of Dermatovenereology, İstanbul, Turkey. Emiroğlu (...) Nazan N Bezmialem Vakıf University Faculty of Medicine, Department of Dermatovenereology, İstanbul, Turkey. Onsun Nahide N Bezmialem Vakıf University Faculty of Medicine, Department of Dermatovenereology, İstanbul, Turkey. eng Letter Mikozis Fungoidesli Hastalarda Sekonder Malignite Sıklığı ve Risk Faktörleri. 2017 08 23 Turkey Turk J Haematol 9606065 1300-7777 IM Adolescent Adult Aged Child Confidence Intervals Female Humans Male Middle Aged Mycosis Fungoides epidemiology Neoplasms, Second Primary

Full Text available with Trip Pro

2017 Turkish Journal of Hematology

130. Low Dose Total Skin Electron Beam Radiation Therapy and Mechlorethamine Hydrochloride Gel in Treating Patients With Mycosis Fungoides

Low Dose Total Skin Electron Beam Radiation Therapy and Mechlorethamine Hydrochloride Gel in Treating Patients With Mycosis Fungoides Low Dose Total Skin Electron Beam Radiation Therapy and Mechlorethamine Hydrochloride Gel in Treating Patients With Mycosis Fungoides - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You (...) have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Low Dose Total Skin Electron Beam Radiation Therapy and Mechlorethamine Hydrochloride Gel in Treating Patients With Mycosis Fungoides The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT03288818

2017 Clinical Trials

131. Secondary Cutaneous Amyloidosis in a Patient with Mycosis Fungoides (PubMed)

Secondary Cutaneous Amyloidosis in a Patient with Mycosis Fungoides Secondary cutaneous amyloidosis refers to clinically unapparent amyloid deposits within the skin in association with a pre-existing skin condition or skin tumors, such as basal cell carcinoma, porokeratosis, solar elastosis, Bowen's disease, and mycosis fungoides. A 70-year-old woman presented with a 6-month history of asymptomatic multiple yellowish plaques on both legs. She had been diagnosed with mycosis fungoides 7 years (...) ago and was treated with psoralen and ultraviolet A radiation (PUVA) therapy, narrow-band ultraviolet B (UVB) therapy, and acitretin for 5 years. Finally, she reached complete remission of mycosis fungoides. However, new yellowish lesions started to appear 1 year after discontinuing the phototherapy. A physical examination revealed multiple yellowish plaques on both extremities. The plaques were well circumscribed and slightly elevated. All laboratory tests were normal. A biopsy specimen showed

Full Text available with Trip Pro

2017 Annals of dermatology

132. Fulminant Mycosis Fungoides with Tissue Eosinophilia: A Unique Presentation of Two Cases with Acro-Periorbital Ulceration and An Aggressive Clinical Course (PubMed)

Fulminant Mycosis Fungoides with Tissue Eosinophilia: A Unique Presentation of Two Cases with Acro-Periorbital Ulceration and An Aggressive Clinical Course We describe two unique cases of fulminant mycosis fungoides with remarkably similar and aggressive clinical courses resulting in death. Both cases demonstrated ulcerated palmar and periorbital plaques and marked tissue eosinophilia, which was confirmed by T-cell receptor γ chain gene rearrangement studies to display identical monoclonality (...) at temporally and anatomically distinct sites. Dense eosinophilic infiltrates on biopsy led to misdiagnosis of inflammatory dermatoses in both instances. While mycosis fungoides may be challenging to diagnose histologically, the presence of eosinophils in progressive disease may herald a poor prognosis and should not exclude the diagnosis.

Full Text available with Trip Pro

2017 Journal of molecular biomarkers & diagnosis

133. Characterization of the peripheral neuropathy associated with brentuximab vedotin treatment of Mycosis Fungoides and Sézary Syndrome (PubMed)

Characterization of the peripheral neuropathy associated with brentuximab vedotin treatment of Mycosis Fungoides and Sézary Syndrome Chemotherapy-induced peripheral neuropathy (CIPN) is common, frequently limits chemotherapy dosing, and negatively impacts quality of life. The National Cancer Institute Common Toxicity Criteria for Adverse Events (CTCAE), version 4.0, and the Total Neuropathy Score clinical version (TNSc) are both validated scores to quantify peripheral neuropathy (PN (...) ), with the TNSc being more sensitive to clinical changes. Mycosis fungoides and Sézary syndrome (MF/SS) are characterized by a chronic course, where current therapies are generally non-curative and treatment toxicities have the potential for significant lasting effects. Brentuximab vedotin (BV) is an antibody-drug-conjugate composed of an anti-CD30 monoclonal antibody linked to the microtubule-disrupting agent, monomethyl auristatin E, with a known associated CIPN. In our phase II clinical trial of BV in MF

Full Text available with Trip Pro

2017 Journal of neuro-oncology

134. Sudden aggravated CD8+ mycosis fungoides accompanied by hidden adenocarcinoma of the colon (PubMed)

Sudden aggravated CD8+ mycosis fungoides accompanied by hidden adenocarcinoma of the colon 28243625 2019 02 26 2352-5126 3 2 2017 Mar JAAD case reports JAAD Case Rep Sudden aggravated CD8 + mycosis fungoides accompanied by hidden adenocarcinoma of the colon. 83-86 10.1016/j.jdcr.2016.12.003 Ahn Hye-Jin HJ Department of Dermatology, School of Medicine, Kyung Hee University, Seoul, Korea. Shin Eun Jae EJ Department of Dermatology, School of Medicine, Kyung Hee University, Seoul, Korea. Gwak Min (...) -Jae MJ Department of Dermatology, School of Medicine, Kyung Hee University, Seoul, Korea. Jeong Ki-Heon KH Department of Dermatology, School of Medicine, Kyung Hee University, Seoul, Korea. Shin Min Kyung MK Department of Dermatology, School of Medicine, Kyung Hee University, Seoul, Korea. eng Case Reports 2017 02 21 United States JAAD Case Rep 101665210 2352-5126 CD8+ mycosis fungoides CTCL, cutaneous T-cell lymphoma FOLFOX, folinic acid, fluorouracil, oxaliplatin MF, mycosis fungoides colon

Full Text available with Trip Pro

2017 JAAD Case Reports

135. PUVA Induced Bullous Pemphigoid in a Patient with Mycosis Fungoides (PubMed)

PUVA Induced Bullous Pemphigoid in a Patient with Mycosis Fungoides Background. Bullous pemphigoid is an autoimmune subepidermal blistering skin disease in which autoantibodies are directed against components of the basement membrane. The disease primarily affects the elderly people and in most of the patients inducing factors cannot be identified. Herein, we report a case of BP that occurred in a patient who was receiving PUVA therapy for the treatment of mycosis fungoides. Main Observation (...) . A 26-year-old woman with mycosis fungoides developed blisters while receiving PUVA therapy. On physical examination tense bullae on the normal skin, remnants of blisters, and erosions were observed on her breasts, the chest wall, and the upper abdomen. Histopathological investigations revealed subepidermal blisters with eosinophilic infiltration and in direct immunofluorescence examination linear deposition of IgG along the basement membrane zone was observed. The diagnosis of bullous pemphigoid

Full Text available with Trip Pro

2017 Case reports in dermatological medicine

136. Concomitant B Hairy Cell Leukemia and Mycosis Fungoides in an Elderly Man (PubMed)

Concomitant B Hairy Cell Leukemia and Mycosis Fungoides in an Elderly Man The development of both a T- and B-cell lymphoproliferative disorder in one patient is an unlikely coincidence due to the low prevalence of each malignancy. We report a 65-year-old man with a previously documented history of B hairy cell leukemia, who presented with a new-onset acneiform eruption of his scalp, face, trunk, back, and extremities. Routine pathology of the skin lesions with immunohistochemical stains (...) and molecular studies were consistent with a folliculotropic mycosis fungoides. B hairy cell leukemia and mycosis fungoides occurring in the same patient seems to be a rare phenomenon with only 5 cases reported in the literature.

Full Text available with Trip Pro

2017 Case reports in dermatology

137. Langerhans cell histiocytosis followed by folliculotropic mycosis fungoides (PubMed)

Langerhans cell histiocytosis followed by folliculotropic mycosis fungoides 28670259 2018 11 13 1642-395X 34 3 2017 Jun Postepy dermatologii i alergologii Postepy Dermatol Alergol Langerhans cell histiocytosis followed by folliculotropic mycosis fungoides. 273-275 10.5114/pdia.2017.67055 Błażewicz Izabela I Department of Dermatology, Venereology and Allergology, Medical University of Gdansk, Gdansk, Poland. Sokołowska-Wojdyło Małgorzata M Department of Dermatology, Venereology and Allergology

Full Text available with Trip Pro

2017 Advances in Dermatology and Allergology/Postȩpy Dermatologii i Alergologii

138. Crazy-Paving Pattern Due to Herpetic Pneumonia in a Patient with Mycosis Fungoides: A Case Report (PubMed)

Crazy-Paving Pattern Due to Herpetic Pneumonia in a Patient with Mycosis Fungoides: A Case Report Herpetic pneumonia in immune deficient patients could be fatal if not treated. Considering the low prevalence of this disease, computed tomography (CT) scan findings of this condition are not well elucidated. This report describes the CT scan findings of a patient with immune system deficiency due to mycosis fungoides, and pneumonia caused by herpes simplex virus 1 (HSV-1). Bilateral alveolar

Full Text available with Trip Pro

2017 Tanaffos

139. An adolescent with granulomatous mycosis fungoides infiltrating skeletal muscle successfully treated with oral prednisone (PubMed)

An adolescent with granulomatous mycosis fungoides infiltrating skeletal muscle successfully treated with oral prednisone 28653029 2019 02 26 2352-5126 3 4 2017 Jul JAAD case reports JAAD Case Rep An adolescent with granulomatous mycosis fungoides infiltrating skeletal muscle successfully treated with oral prednisone. 276-279 10.1016/j.jdcr.2017.03.001 Lewis Daniel J DJ School of Medicine, Baylor College of Medicine, Houston, Texas. Department of Dermatology, University of Texas MD Anderson (...) of Pediatric Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas. Kim Youn H YH Department of Dermatology, Stanford University, Stanford, California. Duvic Madeleine M Department of Dermatology, University of Texas MD Anderson Cancer Center, Houston, Texas. eng Case Reports 2017 06 15 United States JAAD Case Rep 101665210 2352-5126 BSA, body surface area CT, computed tomography GMF, granulomatous mycosis fungoides MF, mycosis fungoides PET, positron emission tomography granulomatous

Full Text available with Trip Pro

2017 JAAD Case Reports

140. Eruptive Seborrheic Keratoses Restricted to Plaque/Patch-Stage Mycosis Fungoides (PubMed)

Eruptive Seborrheic Keratoses Restricted to Plaque/Patch-Stage Mycosis Fungoides Eruptive seborrheic keratoses (ESK) are rare in dermatology. They are usually inflammatory in nature and may be encountered as Leser-Trélat sign. ESK may also be simultaneously observed with hepatic angiomas, chemotherapy, segmental neurofibromatosis, HIV or erythrodermic pityriasis rubra pilaris, psoriasis, and drug eruption. ESK may be transient and self-healing. Others recede after successful treatment (...) of the underlying disease. In some instances, seborrheic keratoses may follow an isotopic response and remain strictly restricted to sites of previous eczema, photo-exposition or tattoos. A patient with patch/plaque lesions of classic-type mycosis fungoides (MF) presented sudden ESK that were exclusively limited to the MF lesions. In conclusion, this patient combined an isotopic response and ESK.

Full Text available with Trip Pro

2017 Case reports in dermatology

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>